Gaudium IVF and Women Health’s ₹150 crore ($18.1 million) initial public offering (IPO) was fully subscribed by the second day of bidding. Strong investor demand across retail, institutional, and non-institutional categories highlights confidence in the company’s growth prospects in India’s expanding healthcare and fertility services sector.
Gaudium IVF and Women Health, a leading fertility and women’s healthcare provider, announced that its $18.1 million IPO has been fully subscribed on the second day of bidding. The offering, valued at approximately ₹150 crore, drew strong interest from investors across categories, reflecting optimism about the company’s expansion plans and sectoral growth.
The IPO proceeds are expected to be utilized for scaling clinical operations, enhancing technological infrastructure, and expanding the company’s footprint in India’s rapidly growing fertility and women’s healthcare market. Analysts note that the oversubscription signals robust investor confidence in healthcare-focused businesses amid rising demand for specialized medical services.
Key Highlights
-
IPO Size: $18.1 million (approx. ₹150 crore).
-
Subscription Status: Fully subscribed by Day 2 of bidding.
-
Investor Interest: Strong demand across retail, institutional, and HNI categories.
-
Utilization of Funds: Expansion of clinical operations and tech infrastructure.
-
Sectoral Context: Rising demand for fertility and women’s healthcare services in India.
-
Market Sentiment: Oversubscription reflects investor confidence in healthcare growth.
Sources: NSE India Market Watch, Moneycontrol, Economic Times